Published in Pharma Investments, Ventures and Law Weekly, September 24th, 2006
As anticipated, the letter was issued in accordance with NASDAQ procedures due to the delayed filing of the company's Form 10-Q for the quarter ended June 30, 2006. Pending a decision by the panel, Affymetrix shares will remain listed on the NASDAQ Stock Market.
On August 9, 2006, the company announced that as a result of its previously...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Investments, Ventures and Law Weekly